Literature DB >> 7591965

Characteristics of the inhibitory effect of mitoxantrone and pirarubicin on lung metastases of colon carcinoma 26.

M Iigo1, M Shimamura, K Sagawa, H Tsuda.   

Abstract

This study was performed to evaluate the antimetastatic activity of antitumor agents against metastatic colon carcinoma 26 (Co 26Lu), and to investigate their mechanisms of action. Pirarubicin demonstrated the most striking antitumor activity in mice bearing intravenously injected Co 26Lu cells. Etoposide and mitoxantrone also showed marked antitumor activity. Pirarubicin and mitoxantrone also exerted remarkable inhibitory effect on spontaneous lung metastases from subcutaneously implanted Co 26Lu. Pirarubicin showed marked inhibition of both primary tumor growth and lung metastases. Mitoxantrone was effective in preventing lung metastases even at doses that did not exhibit an antitumor effect on the primary tumor. Moreover, mitoxantrone administered two days after intravenous injection of tumor cells obviously reduced the number of lung colonies, while simultaneous injection of the drug did not inhibit colony formation. Mitoxantrone effectively inhibited angiogenesis on the chorioallantoic membrane at doses that did not affect the growth rate of embryos. These results suggest that mitoxantrone, besides its direct antitumor effect on tumor cells, may inhibit lung metastases by inhibiting angiogenesis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7591965      PMCID: PMC5920925          DOI: 10.1111/j.1349-7006.1995.tb03098.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  10 in total

1.  Inhibition of angiogenesis by the antineoplastic agents mitoxantrone and bisantrene.

Authors:  P J Polverini; R F Novak
Journal:  Biochem Biophys Res Commun       Date:  1986-11-14       Impact factor: 3.575

2.  Inhibitory effects of anti-angiogenic agents on neovascularization and growth of the chorioallantoic membrane (CAM). The possibility of a new CAM assay for angiogenesis inhibition.

Authors:  N G Tanaka; N Sakamoto; A Tohgo; Y Nishiyama; H Ogawa
Journal:  Exp Pathol       Date:  1986

3.  Tumor angiogenesis inhibition by prostaglandin synthetase inhibitors.

Authors:  H I Peterson
Journal:  Anticancer Res       Date:  1986 Mar-Apr       Impact factor: 2.480

4.  Some characteristics of metastasis in man.

Authors:  E V Sugarbaker
Journal:  Am J Pathol       Date:  1979-12       Impact factor: 4.307

5.  Pharmacokinetics and disposition of 4'-O-tetrahydropyranyladriamycin in mice by HPLC analysis.

Authors:  H Iguchi; H Tone; T Ishikura; T Takeuchi; H Umezawa
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

6.  Induction of vascular endothelial growth factor expression by prostaglandin E2 and E1 in osteoblasts.

Authors:  S Harada; J A Nagy; K A Sullivan; K A Thomas; N Endo; G A Rodan; S B Rodan
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

7.  Pharmacological disposition of 1,4-dihydroxy-5-8-bis[[2 [(2-hydroxyethyl)amino]ethyl]amino]-9,10-anthracenedione dihydrochloride in the dog.

Authors:  K Lu; N Savaraj; T L Loo
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

8.  Effects of mitoxantrone and bisantrene on platelet aggregation and prostaglandin/thromboxane biosynthesis in vitro.

Authors:  P Frank; R F Novak
Journal:  Anticancer Res       Date:  1986 Sep-Oct       Impact factor: 2.480

9.  Effect of eicosapentaenoic acid and other fatty acids on the growth in vitro of human pancreatic cancer cell lines.

Authors:  J S Falconer; J A Ross; K C Fearon; R A Hawkins; M G O'Riordain; D C Carter
Journal:  Br J Cancer       Date:  1994-05       Impact factor: 7.640

10.  Effects of antitumor agents on subcutaneous implants and hepatic metastases of colon carcinoma 26 in mice.

Authors:  M Iigo; K Nishikata; Y Nakajima; E Araki
Journal:  Jpn J Cancer Res       Date:  1992-04
  10 in total
  4 in total

1.  Inhibitory effects of bovine lactoferrin on colon carcinoma 26 lung metastasis in mice.

Authors:  M Iigo; T Kuhara; Y Ushida; K Sekine; M A Moore; H Tsuda
Journal:  Clin Exp Metastasis       Date:  1999-02       Impact factor: 5.150

2.  Liposomal Delivery of Mitoxantrone and a Cholesteryl Indoximod Prodrug Provides Effective Chemo-immunotherapy in Multiple Solid Tumors.

Authors:  Kuo-Ching Mei; Yu-Pei Liao; Jinhong Jiang; Michelle Chiang; Mercedeh Khazaieli; Xiangsheng Liu; Xiang Wang; Qi Liu; Chong Hyun Chang; Xiao Zhang; Juan Li; Ying Ji; Brenda Melano; Donatello Telesca; Tian Xia; Huan Meng; Andre E Nel
Journal:  ACS Nano       Date:  2020-09-25       Impact factor: 15.881

3.  Low-dosage metronomic chemotherapy and angiogenesis: topoisomerase inhibitors irinotecan and mitoxantrone stimulate VEGF-A-mediated angiogenesis.

Authors:  Per Albertsson; Bo Lennernäs; Klas Norrby
Journal:  APMIS       Date:  2011-10-25       Impact factor: 3.205

Review 4.  The Chick Embryo Chorioallantoic Membrane as an In Vivo Assay to Study Antiangiogenesis.

Authors:  Domenico Ribatti
Journal:  Pharmaceuticals (Basel)       Date:  2010-03-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.